NXTS ▲ +10.6% - Nexentis Technologies Inc. $NXTS - Nexentis: MitoCareX Evaluates Expanded Protein Capabilities to Enhance Flexibility and Support Future Drug Discovery Nexentis Technologies shares rose 10.6% today following an announcement that its MitoCareX platform is evaluating expanded protein capabilities designed to increase flexibility and support future drug discovery efforts. The development suggests potential enhancements to the company's core technology platform that could broaden its applicability in the biotech space. 23-SEP-2026 07:07 AM ET